Jorge Nunez
Family Medicine · Hollywood, FLNPI 1629697065
Payments from drug & device makers
Across 117 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$250
- AstraZeneca$226
- Mallinckrodt Hospital Products Inc.$214
- ANI Pharmaceuticals, Inc.$185
- Angiodynamics, Inc.$160
- Novo Nordisk$154
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,441100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $250 |
| AstraZeneca | 12 | $226 |
| Mallinckrodt Hospital Products Inc. | 9 | $214 |
| ANI Pharmaceuticals, Inc. | 6 | $185 |
| Angiodynamics, Inc. | 1 | $160 |
| Novo Nordisk | 8 | $154 |
| Verona Pharma, Inc. | 22 | $151 |
| Exact Sciences | 6 | $125 |
| Pfizer | 6 | $125 |
| Viatris Specialty LLC | 5 | $104 |
| Viiv Healthcare Company | 1 | $104 |
| Lilly USA, LLC | 5 | $91 |
| Sanofi | 3 | $87 |
| Boston Scientific | 2 | $68 |
| Idorsia Pharmaceuticals US Inc | 3 | $66 |
| AbbVie | 3 | $50 |
| Grifols USA, LLC | 2 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Merck | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Corcept Therapeutics | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,441 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $58,414 |
| EliquisApixaban | 31 | $43,081 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $19,553 |
| MounjaroTirzepatide | 19 | $19,406 |
| Novolog FlexpenInsulin Aspart | 19 | $3,445 |
| Atorvastatin Calcium | 174 | $1,280 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $1,244 |
| Levothyroxine Sodium | 97 | $828 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 12 | $699 |
| Gabapentin | 57 | $673 |
| Metoprolol Succinate | 42 | $556 |
| Omeprazole | 41 | $551 |
| Metformin Hcl | 72 | $509 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $465 |
| Losartan Potassium | 69 | $448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $154 | $58,41450 claims |
| PfizerEliquis | $125 | $43,08131 claims |
| GSKTrelegy Ellipta | $250 | $19,55332 claims |
| Lilly USA, LLCMounjaro | $91 | $19,40619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Hollywood
- Sandro BacchelliHollywood$12.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.